A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult Participants
Clinical trial NCT03023852 · COMPLETED
Trial details
- NCT number
- NCT03023852
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-14
- Primary completion
- 2017-04-14
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.